参考文献/References:
[1] Townsend N,Wilson L,Bhatnagar P,et al. Cardiovascular disease in Europe:epidemiological update 2016[J]. Eur Heart J,2016,37(42):3232-3245.
[2] Yonetsu T,Murai T,Kanaji Y,et al. Significance of microvascular function in visual-functional mismatch between invasive coronary angiography and fractional flow reserve[J]. J Am Heart Assoc,2017,6(6):e005916.
[3] Tonino PA,de Bruyne B,Pijls NH,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention[J]. New Engl J Med,2009,360(3):213-224.
[4] Berry C,Corcoran D,Hennigan B,et al. Fractional flow reserve-guided management in stable coronary disease and acute myocardial infarction:recent developments[J]. Eur Heart J,2015,36(45):3155-3164.
[5] Neumann F,Sousa-Uva M,Ahlsson A,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization[J]. EuroIntervention,2019,14(14):1435-1534.
[6] Tu S,Westra J,Yang J,et al. Diagnostic Accuracy of Fast Computational Approaches to Derive?Fractional Flow Reserve From?Diagnostic Coronary Angiography:The International Multicenter FAVOR Pilot Study[J]. JACC Cardiovasc interv,2016,9(19):2024-2035.
[7] Xu B,Tu S,Qiao S,et al. Diagnostic accuracy of angiography-based quantitative flow?ratio measurements for online assessment?of coronary stenosis[J]. J Ame Coll Cardiol,2017,70(25):3077-3087.
[8] Westra J,Andersen BK,Campo G,et al. Diagnostic Performance of In-Procedure Angiography-Derived Quantitative Flow Reserve Compared to Pressure-Derived Fractional Flow Reserve:The FAVORⅡ Europe-Japan Study[J]. J Am Heart Assoc,2018,7(14):e009603
[9] Westra J,Tu S,Winther S,et al. Evaluation of coronary artery stenosis by quantitative flow ratio during invasive coronary angiography:the WIFIⅡ Study (Wire-Free Functional Imaging Ⅱ)[J]. Circ Cardiovasc imaging,2018,11(3):e007107.
[10] Song L,Tu S,Sun Z,et al. Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention:rationale and design of the FAVOR Ⅲ China trial[J]. Am Heart J,2020,223:72-80.
[11] Di Pasquale G,Filippini E,Pavesi PC,et al. Complete versus culprit-only revascularization in ST-elevation myocardial infarction and multivessel disease[J]. Intern Emerg Med,2016,11(4):499-506.
[12] Windecker S,Kolh P,Alfonso F,et al. 2014 ESC/EACTS Guidelines on myocardial revascularization:The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)[J]. Eur Heart J,2014,35(37):2541-2619.
[13] OGara P,Kushner F,Ascheim D,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol,2013,61(4):e78-e140.
[14] Ibanez B,James S,Agewall S,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)[J]. Eur Heart J,2018,39(2):119-177.
[15] Smits PC,Abdel-Wahab M,Neumann FJ,et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction[J]. N Engl J Med,2017,376(13):1234-1244.
[16] Engstr?m T,Kelb?k H,Helqvist S,et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI):an open-label,randomised controlled trial[J]. Lancet,2015,386(9994):665-671.
[17] Sejr-Hansen M,Westra J,Thim T,et al. Quantitative flow ratio for immediate assessment of nonculprit lesions in patients with ST-segment elevation myocardial infarction—An iSTEMI substudy[J]. Catheter Cardiovasc Interv,2019,94(5):686-692.
[18] Lauri F,Macaya F,Mejía-Rería Hnte,et al. Angiography-derived functional assessment of non-culprit coronary stenoses in primary percutaneous coronary intervention[J]. EuroIntervention,2020,15(18):e1594-e1601.
[19] Nam C,Mangiacapra F,Entjes R,et al. Functional SYNTAX score for risk assessment in multivessel coronary artery disease[J]. J Am Coll Cardiol,2011,58(12):1211-1218.
[20] Spitaleri G,Tebaldi M,Biscaglia S,et al. Quantitative flow ratio identifies nonculprit coronary lesions requiring revascularization in patients with ST-segment-elevation myocardial infarction and multivessel disease[J]. Circ Cardiovasc Interv,2018,11(2):e006023.
[21] Asano T,Katagiri Y,Chang C,et al. Angiography-derived fractional flow reserve in the SYNTAXⅡ trial:feasibility,diagnostic performance of quantitative flow ratio,and clinical prognostic value of functional SYNTAX score derived from quantitative flow ratio in patients with 3-vessel disease[J]. JACC Cardiovasc Interv,2019,12(3):259-270.
[22] Tang J,Lai Y,Tu S,et al. Quantitative flow ratio guided residual functional SYNTAX score for risk assessment in patients with st-segment elevation myocardial infarction undergoing percutaneous coronary intervention[J]. EuroIntervention,2019,DOI:10.4244/EIJ-D-19-00369.Epub ahead of print.PMID: 31589145.
[23] Ezekowitz J,Kaul P,Bakal J,et al. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction[J]. J Am Coll Cardiol,2009,53(1):13-20.
[24] de Waha S,Patel M,Granger C,et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction:an individual patient data pooled analysis from seven randomized trials[J]. Eur Heart J,2017,38(47):3502-3510.
[25] Sheng X,Qiao Z,Ge H,et al. Novel application of quantitative flow ratio for predicting microvascular dysfunction after ST-segment-elevation myocardial infarction[J]. Catheter Cardiovasc Interv,2020,Suppl 1:624-632.
[26] de Maria G,Scarsini R,Shanmuganathan M,et al. Angiography-derived index of microcirculatory resistance as a novel,pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarction[J]. Int J Cardiovasc imaging,2020,36(8):1395-1406.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(4):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(4):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(4):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(4):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(4):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(4):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(4):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[9]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(4):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[10]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(4):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]